Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Alkali or alkaline earth chloride
Reexamination Certificate
2007-11-27
2007-11-27
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Alkali or alkaline earth chloride
C424S681000, C424S717000, C514S574000
Reexamination Certificate
active
10020882
ABSTRACT:
The present invention relates to a sterile calcium-free low bicarbonate dialysis concentrate composition for use in conjunction with regional citrate anti-coagulation in the context of either dialysis or hemofiltration. Methods of use of the sterile calcium free low bicarbonate dialysis concentrate compositions are also disclosed. The low bicarbonate concentrate takes into account the fact that citrate is hepatically metabolized into bicarbonate, thus minimizing metabolic complications.
REFERENCES:
patent: 4630727 (1986-12-01), Feriani et al.
patent: 5211643 (1993-05-01), Reinhardt et al.
patent: 5945449 (1999-08-01), Purcell et al.
patent: 6492336 (2002-12-01), Mahiout
patent: 41 14 908 (1992-11-01), None
patent: WO 96/01118 (1996-01-01), None
Chemical Abstracts 124:325351 (1996).
Koo, S.K. et al., “Calcium-free hemodialysis for the management of hypercalcemia,” Nephron, vol. 72, pp. 424-428 (1996).
Yatzidis et al., “Hemodialysis with a New Single Stable Bicarbonate Dialysate”, Nephron, vol. 64, 1993; 27-31.
F. H. Leenen, et al., “Hemodynamic Changes During Acetate and Bicarbonate Hemodialysis”, Artificial Organs 8(4), 1984; 411-417.
M. Kaye et al., “Calcium-free Dialyzate: Development and Applications”, Clinical Nephrology, vol. 31, No. 3, 1989; 132-138.
M. Kaye and D. Fisher, “Changes in Intact Parathyroid Hormone Levels During Hemodialysis Following Exposure to Either Differing Dialyzate,Calcium Concentrations or Calcium-Free Dialysis with Varying Calcium Infusion Rates”, Clinical Nephrology, vol. 34, No. 2, 1990; 84-87.
M. Kaye, “Long-term studies using a calcium-free dialysate”, Clinical Nephrology, vol. 40, No. 4, 1993; 221-224.
P.Y.W. Tam et al., “Slow Continuous Hemodialysis for the Management of Complicated Acute Renal Failure in an Intensive Care Unit”, Clinical Nephrology, vol. 30, No. 2, 1988; 79-85.
E.F.H. Van Bommel et al, “Acute Dialytic Support for the Critically III: Intermittent Hemodialysis Versus Continuous Arteriovenous Hemodiafiltration”, Am. J. Nephrol., vol. 15, 1995; 192-200.
E.F.H. Van Bommel, “Are Continuous Therapies Superior to Intermittent Haemodialysis for Acute Renal Failure on the Intensive Care Unit”, Nephrol Dial. Transplant 1995 Edit. Comm., p. 311.
A. Davenport et al., “Hyperlactataemia and Metabolic Acidosis During Haemofiltration Using Lactate-Buffered Fluids”, Nephron, vol. 59, 1991; 461-465.
M. Leblanc et al., “Bicarbonate Dialysate for Continuous Renal Replacement Therapy in Intensive Care Unit Patients With Acute Renal Failure”, Am. J. Kidney Diseases, vol. 26, No. 6, 1995; 910-917.
Knaus W.A. et al., “APACHE II: A Severity of Disease Classification System”, Critical Care Med., vol. 13, No. 10, 1985; 818-827.
Jordan, D.A. et al., “Evaluation of Sepsis in a Critically ill Surgical Population”, Critical Care Med., vol. 15, No. 10, 1987; 897-904.
LandOfFree
Sterile low bicarbonate dialysis concentrate solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sterile low bicarbonate dialysis concentrate solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sterile low bicarbonate dialysis concentrate solutions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3845997